| # | Title | Journal | Year | Citations |
|---|
| 1 | Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II | Arthritis and Rheumatism | 2008 | 4,029 |
| 2 | American college of rheumatology preliminary definition of improvement in rheumatoid arthritis | Arthritis and Rheumatism | 1995 | 2,531 |
| 3 | Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I | Arthritis and Rheumatism | 2008 | 1,918 |
| 4 | 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis | Arthritis and Rheumatology | 2016 | 1,880 |
| 5 | The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip | Arthritis and Rheumatism | 1991 | 1,879 |
| 6 | Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update | Arthritis and Rheumatism | 2000 | 1,844 |
| 7 | The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis | Arthritis and Rheumatism | 1990 | 1,620 |
| 8 | The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials | Arthritis and Rheumatism | 1993 | 1,388 |
| 9 | 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee | Arthritis Care and Research | 2020 | 1,034 |
| 10 | 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis | Arthritis Care and Research | 2016 | 890 |
| 11 | 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee | Arthritis and Rheumatology | 2020 | 871 |
| 12 | The american college of rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis | Arthritis and Rheumatism | 1992 | 762 |
| 13 | 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis | Arthritis Care and Research | 2021 | 466 |
| 14 | 2020 American College of Rheumatology Guideline for the Management of Gout | Arthritis Care and Research | 2020 | 420 |
| 15 | 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis | Arthritis and Rheumatology | 2019 | 401 |
| 16 | 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis | Arthritis and Rheumatology | 2017 | 399 |
| 17 | Distinctions Between Diagnostic and Classification Criteria? | Arthritis Care and Research | 2015 | 386 |
| 18 | American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis | Arthritis and Rheumatology | 2016 | 383 |
| 19 | 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis | Arthritis and Rheumatology | 2021 | 339 |
| 20 | 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases | Arthritis and Rheumatology | 2020 | 332 |
| 21 | American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1 | Arthritis and Rheumatology | 2020 | 323 |
| 22 | American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2 | Arthritis and Rheumatology | 2021 | 314 |
| 23 | 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis | Arthritis and Rheumatology | 2019 | 312 |
| 24 | 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis | Arthritis Care and Research | 2017 | 303 |
| 25 | 2020 American College of Rheumatology Guideline for the Management of Gout | Arthritis and Rheumatology | 2020 | 302 |
| 26 | 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis | Arthritis Care and Research | 2019 | 274 |
| 27 | 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis | Arthritis Care and Research | 2019 | 264 |
| 28 | 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis | Arthritis and Rheumatology | 2021 | 249 |
| 29 | 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis | Arthritis and Rheumatology | 2021 | 231 |
| 30 | 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis | Arthritis Care and Research | 2019 | 225 |
| 31 | American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3 | Arthritis and Rheumatology | 2021 | 201 |
| 32 | 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis | Arthritis Care and Research | 2019 | 176 |
| 33 | 2015 American College of Rheumatology Workforce Study: Supply and Demand Projections of Adult Rheumatology Workforce, 2015–2030 | Arthritis Care and Research | 2018 | 168 |
| 34 | American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1 | Arthritis and Rheumatology | 2021 | 146 |
| 35 | American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3 | Arthritis and Rheumatology | 2022 | 146 |
| 36 | American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 1 | Arthritis and Rheumatology | 2020 | 142 |
| 37 | American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3 | Arthritis and Rheumatology | 2021 | 126 |
| 38 | 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases | Arthritis Care and Research | 2020 | 122 |
| 39 | 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty | Arthritis and Rheumatology | 2017 | 121 |
| 40 | 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis | Arthritis and Rheumatology | 2019 | 110 |
| 41 | 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty | Arthritis Care and Research | 2017 | 100 |
| 42 | 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis | Arthritis Care and Research | 2021 | 90 |
| 43 | 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis | Arthritis and Rheumatology | 2022 | 68 |
| 44 | ACR Appropriateness Criteria ® Osteoporosis and Bone Mineral Density | Journal of the American College of Radiology | 2017 | 65 |
| 45 | American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 2 | Arthritis and Rheumatology | 2020 | 64 |
| 46 | Rheumatology Informatics System for Effectiveness: A National Informatics‐Enabled Registry for Quality Improvement | Arthritis Care and Research | 2016 | 61 |
| 47 | American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2 | Arthritis and Rheumatology | 2021 | 61 |
| 48 | 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis | Arthritis Care and Research | 2021 | 61 |
| 49 | ACR Appropriateness Criteria ® Suspected Osteomyelitis, Septic Arthritis, or Soft Tissue Infection (Excluding Spine and Diabetic Foot) | Journal of the American College of Radiology | 2017 | 58 |
| 50 | 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis | Arthritis and Rheumatology | 2019 | 57 |
